Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Kumari vitamin Cstandard of careCOVID-19 severe or criticallyNA
75/75 inconclusive
    Jamali Moghadam Siahkali
     
    IRCT20200411047025N1
    RCTvitamin Cstandard of careCOVID-19 severe or criticallyhigh
    30/30 inconclusive
      Zhang
       
      NCT04264533
      RCTvitamin CplaceboCOVID-19 severe or criticallysome concern
      27/29 inconclusive

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).